{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":101,"items":[{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T03:57:51Z","timestamp":1648958271216},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m5212_03_01","type":"standard","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:18:31Z","timestamp":1629123511000},"source":"Crossref","is-referenced-by-count":0,"title":["Metaxalone"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:30:49Z","timestamp":1629124249000},"score":25.254023,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M5212_03_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m5212_03_01"},{"indexed":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T16:42:30Z","timestamp":1658508150666},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m5213_04_01","type":"standard","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T15:59:20Z","timestamp":1658505560000},"source":"Crossref","is-referenced-by-count":0,"title":["Metaxalone Tablets"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T15:59:40Z","timestamp":1658505580000},"score":24.775623,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M5213_04_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m5213_04_01"},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T16:58:02Z","timestamp":1649005082559},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m5213_03_01","type":"standard","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:18:31Z","timestamp":1629123511000},"source":"Crossref","is-referenced-by-count":0,"title":["Metaxalone Tablets"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:49:07Z","timestamp":1629125347000},"score":23.8832,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M5213_03_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m5213_03_01"},{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T02:32:14Z","timestamp":1725589934233},"publisher-location":"Berlin\/Heidelberg","reference-count":0,"publisher":"Springer-Verlag","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1007\/springerreference_39090","type":"reference-entry","created":{"date-parts":[[2011,8,24]],"date-time":"2011-08-24T11:15:55Z","timestamp":1314184555000},"source":"Crossref","is-referenced-by-count":0,"title":["Metaxalone"],"prefix":"10.1007","member":"297","container-title":["SpringerReference"],"language":"en","deposited":{"date-parts":[[2011,8,24]],"date-time":"2011-08-24T11:27:00Z","timestamp":1314185220000},"score":22.368706,"resource":{"primary":{"URL":"http:\/\/www.springerreference.com\/index\/doi\/10.1007\/SpringerReference_39090"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1007\/springerreference_39090"},{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T10:07:22Z","timestamp":1726049242550},"reference-count":1,"publisher":"Qeios","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.32388\/5icjxk","type":"reference-entry","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T18:32:25Z","timestamp":1581100345000},"source":"Crossref","is-referenced-by-count":0,"title":["Metaxalone"],"prefix":"10.32388","author":[{"name":"National Cancer Institute","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17262","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"ref1","unstructured":"National Cancer Institute. Metaxalone. NCI Thesaurus. Code C47606."}],"container-title":["Definitions"],"language":"en","deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T18:32:25Z","timestamp":1581100345000},"score":20.926085,"resource":{"primary":{"URL":"https:\/\/www.qeios.com\/read\/definition\/59470"}},"issued":{"date-parts":[[2020,2,7]]},"references-count":1,"URL":"https:\/\/doi.org\/10.32388\/5icjxk","published":{"date-parts":[[2020,2,7]]}},{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:41:29Z","timestamp":1772131289755,"version":"3.50.1"},"description":"Supplemental Information for 10.1021\/acs.orglett.3c01752","reference-count":0,"publisher":"American Chemical Society (ACS)","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1021\/acs.orglett.3c01752.s001","type":"component","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:01:01Z","timestamp":1688554861000},"source":"Crossref","is-referenced-by-count":0,"title":["Biocatalytic Synthesis of Metaxalone and Its Analogues"],"prefix":"10.1021","member":"316","deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T03:46:56Z","timestamp":1689306416000},"score":20.884579,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/suppl\/10.1021\/acs.orglett.3c01752\/suppl_file\/ol3c01752_si_001.pdf"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1021\/acs.orglett.3c01752.s001","relation":{"is-component-of":[{"id-type":"doi","id":"10.1021\/acs.orglett.3c01752","asserted-by":"object"}]}},{"indexed":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T23:13:04Z","timestamp":1654989184704},"edition-number":"2","reference-count":0,"publisher":"Cambridge University Press","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"unspecified","delay-in-days":1818,"URL":"https:\/\/www.cambridge.org\/core\/terms"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"unspecified","delay-in-days":1818,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2015,10,15]]},"DOI":"10.1017\/9781316161753.085","type":"other","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:08:19Z","timestamp":1601942899000},"page":"312-313","source":"Crossref","is-referenced-by-count":0,"title":["Metaxalone"],"prefix":"10.1017","member":"56","container-title":["Essential Neuropharmacology"],"link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/9AF22E679247F4E824DB058A48B192C7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T22:32:44Z","timestamp":1654986764000},"score":20.179466,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/9781316161753%23c84\/type\/book_part"}},"issued":{"date-parts":[[2015,10,15]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1017\/9781316161753.085","published":{"date-parts":[[2015,10,15]]}},{"indexed":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T22:12:56Z","timestamp":1655071976256},"edition-number":"1","reference-count":3,"publisher":"Cambridge University Press","license":[{"start":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T00:00:00Z","timestamp":1349395200000},"content-version":"unspecified","delay-in-days":29,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2012,9,6]]},"DOI":"10.1017\/cbo9781139194464.067","type":"book-chapter","created":{"date-parts":[[2012,10,6]],"date-time":"2012-10-06T15:04:39Z","timestamp":1349535879000},"page":"298-299","source":"Crossref","is-referenced-by-count":0,"title":["Metaxalone"],"prefix":"10.1017","member":"56","reference":[{"key":"9781139194464.CBO9781139194464A073_CBO9781139194464bib403","unstructured":"See S Ginzburg R Choosing a skeletal muscle relaxant Am Family Phys 2008 78 365"},{"key":"9781139194464.CBO9781139194464A073_CBO9781139194464bib404","doi-asserted-by":"crossref","unstructured":"Toth PP Urtis J Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone Clin Ther 2004 26 1355","DOI":"10.1016\/j.clinthera.2004.09.008"},{"key":"9781139194464.CBO9781139194464A073_CBO9781139194464bib402","doi-asserted-by":"crossref","unstructured":"Chou R Peterson K Helfand M Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review J Pain Symptom Manage 2004 28 140","DOI":"10.1016\/j.jpainsymman.2004.05.002"}],"container-title":["Essential Pain Pharmacology"],"link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/F7AD9B544020CC086997CE30F74C7301","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T21:43:24Z","timestamp":1655070204000},"score":19.803715,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/CBO9781139194464A073\/type\/book_part"}},"issued":{"date-parts":[[2012,9,6]]},"references-count":3,"URL":"https:\/\/doi.org\/10.1017\/cbo9781139194464.067","published":{"date-parts":[[2012,9,6]]}},{"indexed":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T03:02:15Z","timestamp":1726110135901},"edition-number":"0","reference-count":0,"publisher":"CRC Press","isbn-type":[{"type":"electronic","value":"9780429192616"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2015,1,6]]},"DOI":"10.1201\/b17996-85","type":"book-chapter","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T22:27:00Z","timestamp":1607725620000},"page":"227-228","source":"Crossref","is-referenced-by-count":0,"title":["METAXALONE"],"prefix":"10.1201","member":"301","container-title":["Litt's Drug Eruption and Reaction Manual"],"language":"en","deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:12:08Z","timestamp":1618035128000},"score":19.474827,"resource":{"primary":{"URL":"https:\/\/www.taylorfrancis.com\/books\/9781498710039\/chapters\/10.1201\/b17996-85"}},"issued":{"date-parts":[[2015,1,6]]},"ISBN":["9780429192616"],"references-count":0,"URL":"https:\/\/doi.org\/10.1201\/b17996-85","published":{"date-parts":[[2015,1,6]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:28:49Z","timestamp":1648679329109},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[1964,1,25]]},"DOI":"10.1001\/jama.1964.03060170045009","type":"journal-article","created":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T05:07:13Z","timestamp":1322716033000},"page":"291","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Metaxalone"],"prefix":"10.1001","volume":"187","member":"10","container-title":["JAMA"],"language":"en","link":[{"URL":"http:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/1161734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T02:26:57Z","timestamp":1481855217000},"score":19.23601,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.1964.03060170045009"}},"subtitle":["(Skelaxin)"],"issued":{"date-parts":[[1964,1,25]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1964,1,25]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.1964.03060170045009","ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"published":{"date-parts":[[1964,1,25]]}},{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:13:07Z","timestamp":1772125987638,"version":"3.50.1"},"description":"Supplemental Information for 10.1021\/acs.cgd.8b00874","reference-count":0,"publisher":"American Chemical Society (ACS)","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1021\/acs.cgd.8b00874.s001","type":"component","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T08:53:32Z","timestamp":1586422412000},"source":"Crossref","is-referenced-by-count":0,"title":["Solid Phase Behavior, Polymorphism, and Crystal Structure Features of Chiral Drug Metaxalone"],"prefix":"10.1021","member":"316","deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T08:53:32Z","timestamp":1586422412000},"score":19.18236,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/suppl\/10.1021\/acs.cgd.8b00874\/suppl_file\/cg8b00874_si_001.pdf"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1021\/acs.cgd.8b00874.s001","relation":{"is-component-of":[{"id-type":"doi","id":"10.1021\/acs.cgd.8b00874","asserted-by":"object"}]}},{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:05:45Z","timestamp":1772125545043,"version":"3.50.1"},"description":"Supplemental Information for 10.1021\/acs.cgd.0c00497","reference-count":0,"publisher":"American Chemical Society (ACS)","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1021\/acs.cgd.0c00497.s001","type":"component","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T13:46:01Z","timestamp":1592401561000},"source":"Crossref","is-referenced-by-count":0,"title":["Racemic Conglomerate Formation via Crystallization of Metaxalone from Volatile Deep Eutectic Solvents"],"prefix":"10.1021","member":"316","deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T03:57:11Z","timestamp":1593575831000},"score":18.944027,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/suppl\/10.1021\/acs.cgd.0c00497\/suppl_file\/cg0c00497_si_001.pdf"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1021\/acs.cgd.0c00497.s001","relation":{"is-component-of":[{"id-type":"doi","id":"10.1021\/acs.cgd.0c00497","asserted-by":"object"}]}},{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:49:35Z","timestamp":1791859775839,"version":"4.3.4"},"publisher-location":"Berlin, Heidelberg","reference-count":0,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783540206255","type":"print"},{"value":"9783540296621","type":"electronic"}],"license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2004]]},"DOI":"10.1007\/3-540-29662-x_1811","type":"book-chapter","created":{"date-parts":[[2006,2,27]],"date-time":"2006-02-27T17:17:49Z","timestamp":1141060669000},"page":"585-585","source":"Crossref","is-referenced-by-count":0,"title":["Metaxalone"],"prefix":"10.1007","member":"297","container-title":["Rheumatology and Immunology Therapy"],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/3-540-29662-X_1811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:29:59Z","timestamp":1791858599000},"score":18.627949,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/3-540-29662-X_1811"}},"issued":{"date-parts":[[2004]]},"ISBN":["9783540206255","9783540296621"],"references-count":0,"URL":"https:\/\/doi.org\/10.1007\/3-540-29662-x_1811","published":{"date-parts":[[2004]]}},{"indexed":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T06:14:54Z","timestamp":1661494494405},"edition-number":"1","reference-count":4,"publisher":"Cambridge University Press","license":[{"start":{"date-parts":[[2010,12,6]],"date-time":"2010-12-06T00:00:00Z","timestamp":1291593600000},"content-version":"unspecified","delay-in-days":53,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2010,10,14]]},"DOI":"10.1017\/cbo9780511841378.093","type":"book-chapter","created":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T13:35:24Z","timestamp":1297949724000},"page":"372-374","source":"Crossref","is-referenced-by-count":0,"title":["Metaxalone"],"prefix":"10.1017","author":[{"given":"Eric S.","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","reference":[{"key":"9780511841378#c14450-2289_c14450-2308","first-page":"433","article-title":"A study of metaxalone (Skelaxin) vs. placebo in acute musculoskeletal disorders: a cooperative study","volume":"18","author":"Dent","year":"1975","journal-title":"Curr Ther Res Clin Exp"},{"key":"9780511841378#c14450-2289_c14450-2307","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.05.002"},{"key":"9780511841378#c14450-2289_c14450-2306","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2004.09.008"},{"key":"9780511841378#c14450-2289_c14450-2305","volume-title":"Metaxalone (Skelaxin) Prescribing Information","year":"2008"}],"container-title":["The Essence of Analgesia and Analgesics"],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T05:37:51Z","timestamp":1661492271000},"score":18.57582,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/9780511841378%23c14450-2289\/type\/book_part"}},"issued":{"date-parts":[[2010,10,14]]},"references-count":4,"URL":"https:\/\/doi.org\/10.1017\/cbo9780511841378.093","published":{"date-parts":[[2010,10,14]]}},{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T12:24:27Z","timestamp":1725798267085},"edition-number":"1","reference-count":2,"publisher":"Wiley","isbn-type":[{"type":"print","value":"9780470749104"},{"type":"electronic","value":"9781118541203"}],"license":[{"start":{"date-parts":[[2013,10,13]],"date-time":"2013-10-13T00:00:00Z","timestamp":1381622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2013,10,13]]},"DOI":"10.1002\/9781118541203.xen210","type":"other","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T12:42:06Z","timestamp":1412167326000},"page":"1-2","source":"Crossref","is-referenced-by-count":0,"title":["Metaxalone"],"prefix":"10.1002","author":[{"given":"Guangqing","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,10]]},"reference":[{"key":"e_1_2_5_2_1","unstructured":"Metaxalone prescribing information.http:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm."},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00321a004"}],"container-title":["Handbook of Metabolic Pathways of Xenobiotics"],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/9781118541203.xen210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T22:52:44Z","timestamp":1692744764000},"score":18.347483,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9781118541203.xen210"}},"issued":{"date-parts":[[2013,10,13]]},"ISBN":["9780470749104","9781118541203"],"references-count":2,"alternative-id":["10.1002\/9781118541203.xen210","10.1002\/9781118541203"],"URL":"https:\/\/doi.org\/10.1002\/9781118541203.xen210","archive":["Portico"],"published":{"date-parts":[[2013,10,13]]}},{"indexed":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T06:08:59Z","timestamp":1715407739264},"publisher-location":"New York, NY","edition-number":"18","reference-count":0,"publisher":"Springer Publishing Company","isbn-type":[{"value":"9780826135582","type":"print"},{"value":"9780826150356","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1891\/9780826150356.0653","type":"book-chapter","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T23:05:47Z","timestamp":1577142347000},"source":"Crossref","is-referenced-by-count":0,"title":["Metaxalone"],"prefix":"10.1891","member":"793","container-title":["Hale\u2019s Medications &amp; Mothers\u2019 Milk\u2122 2019"],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1891\/9780826150356.0653","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T23:12:49Z","timestamp":1577142769000},"score":18.065243,"resource":{"primary":{"URL":"http:\/\/connect.springerpub.com\/lookup\/doi\/10.1891\/9780826150356.0653"}},"issued":{"date-parts":[[2018,4]]},"ISBN":["9780826135582","9780826150356"],"references-count":0,"alternative-id":["10.1891\/9780826150356"],"URL":"https:\/\/doi.org\/10.1891\/9780826150356.0653","published":{"date-parts":[[2018,4]]}},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T23:30:29Z","timestamp":1649201429562},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s40278-015-8997-2","type":"journal-article","created":{"date-parts":[[2015,3,29]],"date-time":"2015-03-29T03:16:48Z","timestamp":1427599008000},"page":"150-150","source":"Crossref","is-referenced-by-count":0,"title":["Metaxalone overdose"],"prefix":"10.1007","volume":"1544","member":"297","published-online":{"date-parts":[[2015,3,28]]},"reference":[{"issue":"3","key":"8997_CR1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/15563650.2015.1009993","volume":"53","author":"DI Martini","year":"2015","unstructured":"Martini DI, et al. Serotonin syndrome following metaxalone overdose and therapeutic use of a selective serotonin reuptake inhibitor. Clinical Toxicology 53: 185-187, No. 3, Mar 2015. Available from: URL: http:\/\/doi.org\/10.3109\/15563650.2015.1009993 [summarised from an abstract] - USA","journal-title":"Clinical Toxicology"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-015-8997-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40278-015-8997-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-015-8997-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T21:50:15Z","timestamp":1559512215000},"score":17.354256,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40278-015-8997-2"}},"subtitle":["Serotonin syndrome: 2 case reports"],"issued":{"date-parts":[[2015,3]]},"references-count":1,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["8997"],"URL":"https:\/\/doi.org\/10.1007\/s40278-015-8997-2","ISSN":["0114-9954","1179-2051"],"issn-type":[{"value":"0114-9954","type":"print"},{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2015,3]]}},{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:30:47Z","timestamp":1767133847245,"version":"build-2238731810"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[1966,2,7]]},"DOI":"10.1001\/jama.1966.03100060119031","type":"journal-article","created":{"date-parts":[[2011,11,29]],"date-time":"2011-11-29T17:12:08Z","timestamp":1322586728000},"page":"479","source":"Crossref","is-referenced-by-count":14,"title":["Double-Blind Study of Metaxalone"],"prefix":"10.1001","volume":"195","author":[{"given":"Seymour","family":"Diamond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["JAMA"],"language":"en","link":[{"URL":"http:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/658067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T17:58:42Z","timestamp":1481824722000},"score":17.024685,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.1966.03100060119031"}},"subtitle":["Use as Skeletal-Muscle Relaxant"],"issued":{"date-parts":[[1966,2,7]]},"references-count":0,"aliases":["10.1001\/jama.195.6.479"],"journal-issue":{"issue":"6","published-print":{"date-parts":[[1966,2,7]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.1966.03100060119031","ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"published":{"date-parts":[[1966,2,7]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T15:35:29Z","timestamp":1648568129175},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"1074","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.2165\/00128415-200510740-00025","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T00:03:40Z","timestamp":1138320220000},"page":"9","source":"Crossref","is-referenced-by-count":0,"title":["Gabapentin\/metaxalone overdose"],"prefix":"10.1007","volume":"&NA;","author":[{"family":"&NA;","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Reactions Weekly"],"language":"en","deposited":{"date-parts":[[2013,3,2]],"date-time":"2013-03-02T16:34:56Z","timestamp":1362242096000},"score":16.926788,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00128415-200510740-00025"}},"subtitle":["Fatal overdose: case report"],"issued":{"date-parts":[[2005,10]]},"references-count":0,"journal-issue":{"issue":"1074"},"URL":"https:\/\/doi.org\/10.2165\/00128415-200510740-00025","ISSN":["0114-9954"],"issn-type":[{"value":"0114-9954","type":"print"}],"published":{"date-parts":[[2005,10]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T17:58:17Z","timestamp":1649095097568},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s40278-015-5955-y","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T11:41:09Z","timestamp":1444304469000},"page":"165-165","source":"Crossref","is-referenced-by-count":0,"title":["Metaxalone\/venlafaxine"],"prefix":"10.1007","volume":"1571","member":"297","published-online":{"date-parts":[[2015,10,3]]},"reference":[{"issue":"7","key":"5955_CR1","first-page":"687","volume":"53","author":"R Surmaitis","year":"2015","unstructured":"Surmaitis R, et al. Serotonin syndrome associated with therapeutic metaxalone dosing in a patient with cirrhosis. Clinical Toxicology 53: 687, No. 7, 2015. Available from: URL: http:\/\/doi.org\/10.3109\/15563650.2015.1071025 [abstract] - USA","journal-title":"Clinical Toxicology"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-015-5955-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40278-015-5955-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-015-5955-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T21:32:13Z","timestamp":1559511133000},"score":16.594288,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40278-015-5955-y"}},"subtitle":["Serotonin syndrome: case report"],"issued":{"date-parts":[[2015,10]]},"references-count":1,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["5955"],"URL":"https:\/\/doi.org\/10.1007\/s40278-015-5955-y","ISSN":["0114-9954","1179-2051"],"issn-type":[{"value":"0114-9954","type":"print"},{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2015,10]]}}],"items-per-page":20,"query":{"start-index":0,"search-terms":null}}}